SMAD3 Inhibitor, SIS3

SMAD3 Inhibitor, SIS3

CAT N°: 15945
Price:

From 97.00 82.45

SMAD3 is a receptor-regulated intracellular protein that functions downstream of TGF-? and activin receptors and mediates their signaling, playing a role in cell proliferation, differentiation, apoptosis and formation of extracellular matrix. SMAD3 Inhibitor, SIS3 selectively inhibits TGF-? and activin signaling by suppressing Smad3 phosphorylation (IC50 = 3 µM) without affecting the MAPK/p38, ERK, or PI3-kinase signaling pathways.{25955} It has been shown to reduce TGF-?1-induced type 1 procollagen expression and myofibroblast differentiation in normal dermal fibroblasts as well as scleroderma fibroblasts.{25955}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-propen-1-one
  • Correlated keywords
    • 521984-48-5 521985-36-4 specific inhibitors Smad3 transcriptions factors fibrosis extracellular matrix ECM TGF-? activin differentiation inhibits inhibitions TGFs TGF-b TGF-beta TGF-.beta. b ? beta .beta. selective activin Smads 3 three Smad-3 procollagen expressions myofibroblasts dermal fibroblasts scleroderma specifics inhibitors signals signaling cells biology intracellular transduction transforming growth
  • Product Overview:
    SMAD3 is a receptor-regulated intracellular protein that functions downstream of TGF-? and activin receptors and mediates their signaling, playing a role in cell proliferation, differentiation, apoptosis and formation of extracellular matrix. SMAD3 Inhibitor, SIS3 selectively inhibits TGF-? and activin signaling by suppressing Smad3 phosphorylation (IC50 = 3 µM) without affecting the MAPK/p38, ERK, or PI3-kinase signaling pathways.{25955} It has been shown to reduce TGF-?1-induced type 1 procollagen expression and myofibroblast differentiation in normal dermal fibroblasts as well as scleroderma fibroblasts.{25955}

We also advise you